HDAC9 and Alzheimer disease: Some studies point out that enhancement of HAT activity, similar to the HDAC inhibitors in function, is another potential therapeutic approach for AD (Rouaux et al., 2003; Tedeschi et al., 2009; Bousiges et al., 2010; Liu et al., 2012; Park et al., 2013, 2015).